Last Update 01 Nov 25
Fair value Increased 5.14%AMETEK's analyst price target has increased to $216.53 from $205.94. This reflects optimism around improving organic sales, positive order trends, and expectations for margin resilience despite near-term headwinds, according to recent analyst updates.
Analyst Commentary
Recent analyst actions indicate a mix of optimistic and balanced perspectives on AMETEK's fundamentals and valuation. While a number of bullish analysts have raised their price targets and highlighted areas of strength, there are also measured points of caution reflected in the latest research coverage.
Bullish Takeaways- Bullish analysts highlight improving organic sales trends and an increase in positive orders, which points to a supportive environment for revenue growth.
- Margin resilience remains a focus, with analysts expecting the company to manage near-term pressures and preserve profitability.
- Multiple upward price target revisions reflect expectations for continued execution and backlog strength, as well as the company's ability to navigate industry challenges.
- Recent acquisitions are viewed as strategic opportunities to enhance efficiencies and drive incremental value through cost synergies.
- Cautious analysts note that current valuation already captures much of AMETEK's growth and margin outlook, which could make further upside more challenging.
- There is wariness regarding potential margin pressure from tariff-related headwinds, with expectations that this could constrain profitability through at least 2025.
- Muted expectations for organic growth in the near term along with prudently lackluster assumptions for multi-industry earnings temper the bullish case.
- Some analysts have adopted a more neutral stance, seeing most negative catalysts as already priced in and waiting for clear signs of further upside before becoming more constructive.
What's in the News
- AMETEK provided sales guidance for the fourth quarter of 2025, with overall sales projected to increase by approximately 10% compared to the same period last year. (Key Developments)
- The company reaffirmed its full-year sales guidance for 2025. The company expects overall sales growth to be in the mid-single digits relative to 2024. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has increased from $205.94 to $216.53, reflecting a moderate upward revision in estimated fair value.
- Discount Rate has risen slightly from 8.73% to 9.14%, which indicates a marginally higher expected return requirement by the market.
- Revenue Growth assumptions have edged down, declining modestly from 7.92% to 7.73% year-over-year.
- Net Profit Margin expectation has improved marginally, with estimates moving from 21.27% to 21.37%.
- Future P/E ratio forecast has increased from 32.48x to 33.67x. This implies a higher valuation placed on expected future earnings.
Key Takeaways
- Expansion in digital automation and sustainability markets, combined with disciplined acquisitions, is driving recurring revenue growth and increasing margins across key sectors.
- Strong R&D investment enables ongoing innovation, supporting high-margin product launches and steady gains in market share and profitability.
- Weakness in key end markets, reliance on acquisitions, and digital competition pose sustained risks to growth, margins, and long-term profitability.
Catalysts
About AMETEK- Manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally.
- Adoption of digital reality, automation, and advanced metrology solutions is accelerating across key end markets such as aerospace, defense, and architecture-recently reinforced by the FARO Technologies acquisition-expanding AMETEK's addressable market and supporting both revenue and margin growth through higher value, software-enabled recurring revenue streams.
- Growing global focus on sustainability and energy efficiency, alongside regulatory requirements across sectors (e.g., energy, grid modernization, environmental labs), is driving long-term demand for high-precision analytical and monitoring instrumentation, favoring AMETEK's portfolio and supporting steady revenue and market share gains.
- Sustained robust investment in R&D-reflected in a high vitality index and recent product launches (e.g., SPECTROGREEN MS for environmental and pharmaceutical analysis)-positions AMETEK for ongoing innovation, higher-margin product introductions, and net margin expansion as industries demand more sophisticated, reliable measurement solutions.
- EMG and Automation segments are inflecting upwards, with destocking now complete and record orders translating to accelerating organic growth and strong core margin expansion; this shift is poised to further enhance operating leverage and group EBITDA growth in coming quarters.
- Ongoing successful execution of a disciplined M&A strategy, leveraging a robust acquisition pipeline and significant balance sheet capacity, provides a catalyst for compounding top-line and EPS growth, while integration synergies and operational excellence drive expansion of operating and EBITDA margins.
AMETEK Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming AMETEK's revenue will grow by 7.9% annually over the next 3 years.
- Analysts assume that profit margins will increase from 20.6% today to 21.3% in 3 years time.
- Analysts expect earnings to reach $1.9 billion (and earnings per share of $8.15) by about September 2028, up from $1.4 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 32.5x on those 2028 earnings, up from 30.1x today. This future PE is lower than the current PE for the US Electrical industry at 33.7x.
- Analysts expect the number of shares outstanding to decline by 0.15% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.73%, as per the Simply Wall St company report.
AMETEK Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Persistent weakness in the process and analytical segment, particularly due to sluggish conditions in semiconductor and research/academia end markets-segments that together represent a sizable portion of AMETEK's sales-may limit organic revenue growth and create sustained headwinds for overall top-line expansion.
- Prolonged uncertainty in global trade dynamics, including tariffs and delays in project funding (especially in China), introduces volatility that could disrupt order timing, reduce visibility, and impact revenue recognition, potentially compressing margins if mitigation actions lose effectiveness.
- Overreliance on M&A for growth-as indicated by the expectation to drive enhanced top-line and margin expansion through acquisitions like FARO and Paragon-raises the risk of integration missteps, overpayment, or underperformance, which could dilute return on invested capital and lead to goodwill impairments, thus affecting net income.
- Competitive threats from industry digitization and potential commoditization in core instrumentation markets, especially as cloud-based analytics and software-driven solutions become more prevalent, may erode AMETEK's hardware-centric value proposition and pressure long-term net margins.
- Ongoing delays and reductions in academic and government research funding, which constitute roughly 10% of company revenues and are currently cited as a headwind, could persist longer term, capping growth opportunities in those end markets and dampening earnings potential.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $205.938 for AMETEK based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $225.0, and the most bearish reporting a price target of just $168.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $8.8 billion, earnings will come to $1.9 billion, and it would be trading on a PE ratio of 32.5x, assuming you use a discount rate of 8.7%.
- Given the current share price of $187.48, the analyst price target of $205.94 is 9.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

